Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.
about
Interferons in Sjögren's Syndrome: Genes, Mechanisms, and EffectsSalivary gland hypofunction induced by activation of innate immunity is dependent on type I interferon signaling.MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.Candidate chromosome 1 disease susceptibility genes for Sjogren's syndrome xerostomia are narrowed by novel NOD.B10 congenic mice.Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome.Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromesActivation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome.Genetic and pharmacologic inhibition of the Ca2+ influx channel TRPC3 protects secretory epithelia from Ca2+-dependent toxicity.Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndromeThe dysregulation of cytokine networks in systemic lupus erythematosus.Transcriptome analysis of the interferon-signature defining the autoimmune process of Sjögren's syndromeSensors of the innate immune system: their link to rheumatic diseases.Peripheral blood gene expression profiling in Sjögren's syndromeTreating Sjögren's Syndrome: Insights for the ClinicianB cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue.Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy.Sjögren's syndrome--a plethora of clinical and immunological phenotypes with a complex genetic background.Epistasis with HLA DR3 implicates the P2X7 receptor in the pathogenesis of primary Sjögren's syndrome.The interferon-inducible HIN-200 gene family in apoptosis and inflammation: implication for autoimmunity.Update on the role of plasmacytoid dendritic cells in inflammatory/autoimmune skin diseases.Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD.Epistasis between the MHC and the RCA alpha block in primary Sjögren syndrome.Irgm1 coordinately regulates autoimmunity and host defense at select mucosal surfaces.Marathon of eponyms: 19 Sjögren syndrome.
P2860
Q26865427-8BEB9DEC-B9F2-4F2A-879D-385263029BE1Q30415532-B3CF5AA7-6517-4BD7-A627-5FD554CB911DQ33659118-C3FBB05D-F979-476E-8382-A79694F3928FQ33758184-899BB063-C6CE-47EE-87A5-83218E62BC39Q33798937-99DA0D5D-3D92-41A3-A2FE-53E68D5393B3Q34083843-D3CDE1E5-C70A-4AB9-8205-3D6866FE50C9Q34103317-5F00584E-53CB-462F-A3A2-99FD7EA4B8FFQ35028058-545F8E16-71A6-4E7C-918A-72EDFFDAF68EQ35082778-AA343F95-0239-4146-B2B7-3505404144E1Q35294513-D64162A7-7BCB-495C-8C87-4AC64832D63CQ35535151-AF3C51F9-A5A7-48B5-ABBC-85ED189BE793Q35623130-F39CECD1-4D13-4CD9-ACED-942A54531BC8Q35740973-0872C5DD-1235-4A97-A685-E7C8ABE63E7CQ36056942-765469D6-0D22-405D-993E-0FB5CD208EE0Q36392366-82A5BF87-3A54-4768-87A2-E6C2197A466BQ36633351-04B7FA58-0D69-4A97-AC1D-64671477DAC6Q36951063-84BDF834-18B3-4657-842F-904C6D6A5748Q37691215-57FA3AC0-8057-41D3-A427-EA9B482D6214Q37699343-4F9E9C75-B3C0-4568-8099-4155653BD67CQ38720050-713E298B-61B7-456B-B118-52669FDE5BB0Q39628016-433FCCE9-FD94-426A-B6BD-796EC2BA2D67Q42128563-88CEBBED-1C91-4A7A-A5C4-F9C0D4D95425Q42367663-4DC834C0-952E-4CCB-83CA-BF3EEDAC957FQ45260730-46466045-6BC8-45EB-A101-C9FC8552BF08
P2860
Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.
@ast
Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.
@en
type
label
Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.
@ast
Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.
@en
prefLabel
Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.
@ast
Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.
@en
P2093
P2860
P356
P1476
Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.
@en
P2093
Gunnar V Alm
Gunnel Nordmark
Lars Rönnblom
P2860
P304
P356
10.1038/NCPRHEUM0173
P577
2006-05-01T00:00:00Z